Prisma Health is honoring its Cancer Institute Medical Director Dr. W. Larry Gluck ahead of his retirement on May 12 by establishing a $3 million endowment, the W. Larry Gluck, MD Endowed Chair of Transitional Molecular Oncology Research.
The chair was created to honor Gluck’s almost 40-year tenure with the health care system and will be used to help attract and fund a lead physician-scientist’s work.
During Gluck’s career, the Cancer Institute has grown to 30 physicians and 450 team members across 10 sites and five counties. Under his leadership, the facility was designated as a National Cancer Institute Cancer Center.
Gluck also oversaw the creation of research programs such as:
- Institute for Translational Oncology Research – provides access to personalized clinical trial options such as a rare-tumor clinic and a pioneering blood and marrow transplant program.
- Center for Integrative Oncology and Survivorship — provides aid for longterm challenges as a result of surgery, chemotherapy and radiation treatments.
- Center for Cancer Prevention and Wellness – helps reduce cancer risk through free wellness screenings and lifestyle change.
Gluck has also served as a professor of medicine at the University of South Carolina School of Medicine Greenville.
“As a life-long academic physician-scientist, Dr. Gluck transformed cancer care delivery through his clinical research and exceptional patient care,” said Jonathan Gleason, MD, Prisma Health’s chief clinical officer. “His leadership in helping establish the state-of-the-art Prisma Health Cancer Institute, and now this endowment, will continue to fortify Prisma Health as the premier model for cancer research and patient care.”
For more information, visit prismahealthupstategiving.org/gluck.
